List of Tables
Table 1. Cancer Drugs Market Trends
Table 2. Cancer Drugs Market Drivers & Opportunity
Table 3. Cancer Drugs Market Challenges
Table 4. Cancer Drugs Market Restraints
Table 5. Global Cancer Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cancer Drugs Revenue Market Share by Company (2019-2024)
Table 7. Global Cancer Drugs Sales Volume by Company (2019-2024) & (K MT)
Table 8. Global Cancer Drugs Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Cancer Drugs Price by Company (2019-2024) & (USD/MT)
Table 10. Key Manufacturers Cancer Drugs Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Cancer Drugs Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Cancer Drugs
Table 13. Global Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Drugs as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Cancer Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Cancer Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Cancer Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Cancer Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Cancer Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Cancer Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)
Table 22. Global Cancer Drugs Sales Volume by Type (2019-2024) & (K MT)
Table 23. Global Cancer Drugs Sales Volume by Type (2025-2030) & (K MT)
Table 24. Global Cancer Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Cancer Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Cancer Drugs Price by Type (2019-2024) & (USD/MT)
Table 27. Global Cancer Drugs Price by Type (2025-2030) & (USD/MT)
Table 28. Global Cancer Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Cancer Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Cancer Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Cancer Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Cancer Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Cancer Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)
Table 34. Global Cancer Drugs Sales Volume by Application (2019-2024) & (K MT)
Table 35. Global Cancer Drugs Sales Volume by Application (2025-2030) & (K MT)
Table 36. Global Cancer Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Cancer Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Cancer Drugs Price by Application (2019-2024) & (USD/MT)
Table 39. Global Cancer Drugs Price by Application (2025-2030) & (USD/MT)
Table 40. Global Cancer Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Cancer Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Cancer Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Cancer Drugs Sales Value by Region (2019-2024) & (%)
Table 44. Global Cancer Drugs Sales Value by Region (2025-2030) & (%)
Table 45. Global Cancer Drugs Sales Volume by Region (K MT): 2019 VS 2023 VS 2030
Table 46. Global Cancer Drugs Sales Volume by Region (2019-2024) & (K MT)
Table 47. Global Cancer Drugs Sales Volume by Region (2025-2030) & (K MT)
Table 48. Global Cancer Drugs Sales Volume by Region (2019-2024) & (%)
Table 49. Global Cancer Drugs Sales Volume by Region (2025-2030) & (%)
Table 50. Global Cancer Drugs Average Price by Region (2019-2024) & (USD/MT)
Table 51. Global Cancer Drugs Average Price by Region (2025-2030) & (USD/MT)
Table 52. Key Countries/Regions Cancer Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Cancer Drugs Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Cancer Drugs Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Cancer Drugs Sales Volume, (2019-2024) & (K MT)
Table 56. Key Countries/Regions Cancer Drugs Sales Volume, (2025-2030) & (K MT)
Table 57. Roche Company Information
Table 58. Roche Introduction and Business Overview
Table 59. Roche Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Roche Cancer Drugs Product Offerings
Table 61. Roche Recent Development
Table 62. Novartis Company Information
Table 63. Novartis Introduction and Business Overview
Table 64. Novartis Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 65. Novartis Cancer Drugs Product Offerings
Table 66. Novartis Recent Development
Table 67. Celgene Company Information
Table 68. Celgene Introduction and Business Overview
Table 69. Celgene Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 70. Celgene Cancer Drugs Product Offerings
Table 71. Celgene Recent Development
Table 72. Bristol-Myers Squibb Company Information
Table 73. Bristol-Myers Squibb Introduction and Business Overview
Table 74. Bristol-Myers Squibb Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 75. Bristol-Myers Squibb Cancer Drugs Product Offerings
Table 76. Bristol-Myers Squibb Recent Development
Table 77. Amgen Company Information
Table 78. Amgen Introduction and Business Overview
Table 79. Amgen Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 80. Amgen Cancer Drugs Product Offerings
Table 81. Amgen Recent Development
Table 82. Johnson & Johnson Company Information
Table 83. Johnson & Johnson Introduction and Business Overview
Table 84. Johnson & Johnson Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 85. Johnson & Johnson Cancer Drugs Product Offerings
Table 86. Johnson & Johnson Recent Development
Table 87. Pfizer Company Information
Table 88. Pfizer Introduction and Business Overview
Table 89. Pfizer Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 90. Pfizer Cancer Drugs Product Offerings
Table 91. Pfizer Recent Development
Table 92. Takeda Company Information
Table 93. Takeda Introduction and Business Overview
Table 94. Takeda Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 95. Takeda Cancer Drugs Product Offerings
Table 96. Takeda Recent Development
Table 97. Eli Lilly Company Information
Table 98. Eli Lilly Introduction and Business Overview
Table 99. Eli Lilly Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 100. Eli Lilly Cancer Drugs Product Offerings
Table 101. Eli Lilly Recent Development
Table 102. AstraZeneca Company Information
Table 103. AstraZeneca Introduction and Business Overview
Table 104. AstraZeneca Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 105. AstraZeneca Cancer Drugs Product Offerings
Table 106. AstraZeneca Recent Development
Table 107. Astellas Company Information
Table 108. Astellas Introduction and Business Overview
Table 109. Astellas Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 110. Astellas Cancer Drugs Product Offerings
Table 111. Astellas Recent Development
Table 112. Merck & Co. Company Information
Table 113. Merck & Co. Introduction and Business Overview
Table 114. Merck & Co. Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 115. Merck & Co. Cancer Drugs Product Offerings
Table 116. Merck & Co. Recent Development
Table 117. Sanofi Company Information
Table 118. Sanofi Introduction and Business Overview
Table 119. Sanofi Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 120. Sanofi Cancer Drugs Product Offerings
Table 121. Sanofi Recent Development
Table 122. Bayer Company Information
Table 123. Bayer Introduction and Business Overview
Table 124. Bayer Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 125. Bayer Cancer Drugs Product Offerings
Table 126. Bayer Recent Development
Table 127. Biogen Idec Company Information
Table 128. Biogen Idec Introduction and Business Overview
Table 129. Biogen Idec Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 130. Biogen Idec Cancer Drugs Product Offerings
Table 131. Biogen Idec Recent Development
Table 132. Eisai Company Information
Table 133. Eisai Introduction and Business Overview
Table 134. Eisai Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 135. Eisai Cancer Drugs Product Offerings
Table 136. Eisai Recent Development
Table 137. Teva Company Information
Table 138. Teva Introduction and Business Overview
Table 139. Teva Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 140. Teva Cancer Drugs Product Offerings
Table 141. Teva Recent Development
Table 142. Otsuka Company Information
Table 143. Otsuka Introduction and Business Overview
Table 144. Otsuka Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 145. Otsuka Cancer Drugs Product Offerings
Table 146. Otsuka Recent Development
Table 147. Merck KGaA Company Information
Table 148. Merck KGaA Introduction and Business Overview
Table 149. Merck KGaA Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 150. Merck KGaA Cancer Drugs Product Offerings
Table 151. Merck KGaA Recent Development
Table 152. Ipsen Company Information
Table 153. Ipsen Introduction and Business Overview
Table 154. Ipsen Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 155. Ipsen Cancer Drugs Product Offerings
Table 156. Ipsen Recent Development
Table 157. AbbVie Company Information
Table 158. AbbVie Introduction and Business Overview
Table 159. AbbVie Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 160. AbbVie Cancer Drugs Product Offerings
Table 161. AbbVie Recent Development
Table 162. Gilead Sciences Company Information
Table 163. Gilead Sciences Introduction and Business Overview
Table 164. Gilead Sciences Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 165. Gilead Sciences Cancer Drugs Product Offerings
Table 166. Gilead Sciences Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Cancer Drugs Downstream Customers
Table 170. Cancer Drugs Distributors List
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Drugs Product Picture
Figure 2. Global Cancer Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Cancer Drugs Sales Volume (2019-2030) & (K MT)
Figure 5. Global Cancer Drugs Sales Price (2019-2030) & (USD/MT)
Figure 6. Cancer Drugs Report Years Considered
Figure 7. Global Cancer Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Cancer Drugs Players Sales Volume Ranking (2023) & (K MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cancer Drugs Revenue in 2023
Figure 10. Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Chemotherapy Picture
Figure 12. Targeted Therapy Picture
Figure 13. Immunotherapy Picture
Figure 14. Hormonal Therapy (Biologic Therapy) Picture
Figure 15. Others Picture
Figure 16. Global Cancer Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Cancer Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 18. Global Cancer Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)
Figure 19. Global Cancer Drugs Sales Volume Market Share by Type, 2023 & 2030
Figure 20. Global Cancer Drugs Price by Type (2019-2030) & (USD/MT)
Figure 21. Product Picture of Blood Cancer
Figure 22. Product Picture of Breast Cancer
Figure 23. Product Picture of Gastrointestinal Cancer
Figure 24. Product Picture of Prostate Cancer
Figure 25. Product Picture of Respiratory/Lung Cancer
Figure 26. Product Picture of Other Cancers
Figure 27. Global Cancer Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 28. Global Cancer Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 29. Global Cancer Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)
Figure 30. Global Cancer Drugs Sales Volume Market Share by Application, 2023 & 2030
Figure 31. Global Cancer Drugs Price by Application (2019-2030) & (USD/MT)
Figure 32. North America Cancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 33. North America Cancer Drugs Sales Value by Country (%), 2023 VS 2030
Figure 34. Europe Cancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 35. Europe Cancer Drugs Sales Value by Country (%), 2023 VS 2030
Figure 36. Asia Pacific Cancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Cancer Drugs Sales Value by Country (%), 2023 VS 2030
Figure 38. South America Cancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 39. South America Cancer Drugs Sales Value by Country (%), 2023 VS 2030
Figure 40. Middle East & Africa Cancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Cancer Drugs Sales Value by Country (%), 2023 VS 2030
Figure 42. Key Countries/Regions Cancer Drugs Sales Value (%), (2019-2030)
Figure 43. Key Countries/Regions Cancer Drugs Sales Volume (%), (2019-2030)
Figure 44. United States Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 45. United States Cancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 46. United States Cancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 47. Europe Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 48. Europe Cancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 49. Europe Cancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 50. China Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 51. China Cancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 52. China Cancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 53. Japan Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 54. Japan Cancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 55. Japan Cancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 56. South Korea Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 57. South Korea Cancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 58. South Korea Cancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 59. Southeast Asia Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 60. Southeast Asia Cancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 61. Southeast Asia Cancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 62. India Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 63. India Cancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 64. India Cancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 65. Cancer Drugs Industrial Chain
Figure 66. Cancer Drugs Manufacturing Cost Structure
Figure 67. Channels of Distribution (Direct Sales, and Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
